Longer time to all-cause antipsychotic discontinuation is associated with better schizophrenia treatment outcomes

被引：0
|
作者：
Dunayevich, E
Zhao, FY
Ascher-Svanum, H
Mitchell, CP
Phillips, GA
Dellva, MA
Green, A
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Dartmouth Hlth & Med Ctr, Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA
来源：
BIOLOGICAL PSYCHIATRY | 2005年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
390
引用
收藏
页码：107S / 107S
页数：1
相关论文
共 50 条
  • [21] Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies
    Kroken, Rune A.
    Kjelby, Eirik
    Wentzel-Larsen, Tore
    Mellesdal, Liv S.
    Jorgensen, Hugo A.
    Johnsen, Erik
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (06) : 228 - 239
  • [22] TIME TO DISCONTINUATION OF ANTIPSYCHOTIC DRUGS IN A SCHIZOPHRENIA COHORT: INFLUENCE OF CURRENT TREATMENT STRATEGIES
    Kroken, Rune A.
    Kjelby, Eirik
    Wentzel-Larsen, Tore
    Mellesdal, Liv S.
    Jorgensen, Hugo A.
    Johnsen, Erik
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S354 - S354
  • [23] A systematic review of comparative time to all cause discontinuation of antipsychotic medications in first episode psychosis
    Brooke, Alice
    Whale, Richard
    Bucur, Mihaela
    BJPSYCH OPEN, 2021, 7 : S240 - S240
  • [24] Antipsychotic treatment and risk of discontinuation of cardiometabolic drugs in schizophrenia
    Solmi, M.
    Tiihonen, J.
    Lahteenvuo, M.
    Tanskanen, A.
    Correll, C. U.
    Taipale, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S352 - S352
  • [25] Treatment discontinuation in antipsychotic trials and change in schizophrenia symptoms
    Landbloom, R
    Meyers, AL
    Adams, DH
    Ascher-Svanum, H
    Kinon, BJ
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 88 - 89
  • [26] Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
    Mullins, C. Daniel
    Obeidat, Nour A.
    Cuffel, Brian J.
    Naradzay, John
    Loebel, Antony D.
    SCHIZOPHRENIA RESEARCH, 2008, 98 (1-3) : 8 - 15
  • [27] Treatment discontinuation in antipsychotic trials and change in schizophrenia symptoms
    Kinon, BJ
    Meyers, A
    Adams, DH
    Ascher-Svanum, H
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 29S - 29S
  • [28] Treatment discontinuation in antipsychotic trials and change in schizophrenia symptoms
    Meyers, A.
    Kinon, B.
    Adams, D.
    Ascher-Svanum, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S151 - S151
  • [29] Discontinuation of Antiplatelet Treatment and Risk of Recurrent Stroke and All-Cause Death: A Cohort Study
    Ostergaard, Kamilla
    Pottegard, Anton
    Hallas, Jesper
    Bak, Soren
    Christensen, Rene dePont
    Gaist, David
    NEUROEPIDEMIOLOGY, 2014, 43 (01) : 57 - 64
  • [30] ANTIPSYCHOTIC MEDICATIONS AND RISK OF ALL-CAUSE, NATURAL, AND SUICIDE MORTALITY IN PATIENTS WITH SCHIZOPHRENIA: A NATIONWIDE COHORT STUDY
    Kuo, Chian-Jue
    Chen, Wen-Yin
    Chen, Pao-Huan
    Tsai, Shang-Ying
    Chen, Chiao-Chicy
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i166 - i166
12345